The munKNEE Canadian Cannabis LPs Index tracks the performance of the 5 largest vertically integrated (i.e. seed-to-sale) licensed producers by market capitalization. Also presented are links to my summary articles on their latest quarter financial results and a link to a recent article which highlights the financial health of each constituent.

Below is how the constituents performed last week, in descending order, and since the end of November 2022:

1. Tilray (TLRY): UP 10.5% last week; DOWN 23.8% since the end of November
   • Read: Tilray Brands' Q1 Financials Show Major Improvement Over Previous Quarter
2. OrganiGram (OGI): UP 5.1% last week; DOWN 20.4% since the end of November
   • Read: Organigram Q4 Financial Results: Record Net Revenue; Positive Adjusted EBITDA
3. Canopy Growth (CGC): UP 4.8% last week; DOWN 34.4% since the end of November
   • Read: Canopy Growth Q2 Financial Report: Loss In Net Income Reduced Dramatically
4. Cronos (CRON): UP 0.8% last week; DOWN 18.3% since the end of November
   • Read: Cronos Group Q3 Financial Report Disappointing: Stock Declines 10%
5. Aurora (ACB): DOWN 1.1% last week; DOWN 31.3% since the end of November
   • Read: Aurora Cannabis Q1 Financials Show Improvement: Stock Jumps 18%

In total, the munKNEE Canadian Cannabis LPs Index went UP 4.8% last week but is DOWN 25.9% since the end of November, 2022. The munKNEE  American Cannabis MSO Stocks Index, in comparison, went UP 4.9% last week but remains DOWN 39.8% since the end of November. 

More By This Author:

My "Rags-To-Riches" Portfolio For 2023: An Introduction
The Highest ESG Score ETFs Index Outperformed The S&P 500 In 2022
The 5 Cannabis Category Indices Ranged From +0.39% To -72.2% In 2022